Product Information
POTASSIUM CITRATE ER 5 MEQ TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1348 per EA under NDC 16571086401. Its NADAC has been published 55 times since Jun 11, 2025.
Strength
540 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571086401
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
POTASSIUM CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA077440On Market Since
12/15/2024
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has been published 55 times since Jun 11, 2025, and over the history we have for it it has declined 18.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1348 per EA |
|---|---|
| All-time high | $0.1648 (Jun 11, 2025) |
| All-time low | $0.1217 (Mar 18, 2026) |
| 52-week high | $0.1499 |
| 52-week low | $0.1217 |
| Median price | $0.1289 |
| Average price | $0.1307 |
| Largest weekly change | -9.1% (Jun 18, 2025) |
| Weeks tracked | 55 |
| Tracking since | Jun 11, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the potassium citrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of POTASSIUM CITRATE ER 5 MEQ TAB?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 5 MEQ TAB, manufactured by Rising Pharma Holdings Inc., is $0.1348 per EA (NDC 16571086401), effective Jun 24, 2026.
How has the price of POTASSIUM CITRATE ER 5 MEQ TAB changed over time?
Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has declined 18.2%. It has been tracked across 55 weekly CMS publications since Jun 11, 2025.
What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 5 MEQ TAB?
Since Jun 11, 2025, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has ranged from a low of $0.1217 (Mar 18, 2026) to a high of $0.1648 (Jun 11, 2025), with a median of $0.1289 per EA.
Are there cheaper alternatives to POTASSIUM CITRATE ER 5 MEQ TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of POTASSIUM CITRATE ER 5 MEQ TAB, so no direct lower-cost alternative is listed.
Who manufactures POTASSIUM CITRATE ER 5 MEQ TAB?
POTASSIUM CITRATE ER 5 MEQ TAB (NDC 16571086401) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification